Literature DB >> 28197918

Sumoylation: Implications for Neurodegenerative Diseases.

Dina B Anderson1, Camila A Zanella2, Jeremy M Henley3, Helena Cimarosti4.   

Abstract

The covalent posttranslational modifications of proteins are critical events in signaling cascades that enable cells to efficiently, rapidly and reversibly respond to extracellular stimuli. This is especially important in the CNS where the processes affecting synaptic communication between neurons are highly complex and very tightly regulated. Sumoylation regulates the function and fate of a diverse array of proteins and participates in the complex cell signaling pathways required for cell survival. One of the most complex signaling pathways is synaptic transmission.Correct synaptic function is critical to the working of the brain and its alteration through synaptic plasticity mediates learning, mental disorders and stroke. The investigation of neuronal sumoylation is a new and exciting field and the functional and pathophysiological implications are far-reaching. Sumoylation has already been implicated in a diverse array of neurological disorders. Here we provide an overview of current literature highlighting recent insights into the role of sumoylation in neurodegeneration. In addition we present a brief assessment of drug discovery in the analogous ubiquitin system and extrapolate on the potential for development of novel therapies that might target SUMO-associated mechanisms of neurodegenerative disease.

Entities:  

Keywords:  Alzheimer’s disease; Amyotrophic lateral sclerosis; Drug targets; Ischemia; Neuronal intranuclear inclusion disease; Parkinson’s disease; Polyglutamine diseases

Mesh:

Substances:

Year:  2017        PMID: 28197918     DOI: 10.1007/978-3-319-50044-7_16

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  20 in total

Review 1.  The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention.

Authors:  Abdelmagid M Elmatboly; Ahmed M Sherif; Dalia A Deeb; Amira Benmelouka; May N Bin-Jumah; Lotfi Aleya; Mohamed M Abdel-Daim
Journal:  Environ Sci Pollut Res Int       Date:  2020-02-19       Impact factor: 4.223

Review 2.  Sumoylation in Physiology, Pathology and Therapy.

Authors:  Umut Sahin; Hugues de Thé; Valérie Lallemand-Breitenbach
Journal:  Cells       Date:  2022-02-26       Impact factor: 6.600

3.  Hyper-SUMOylation of SMN induced by SENP2 deficiency decreases its stability and leads to spinal muscular atrophy-like pathology.

Authors:  Yuhong Zhang; Xu Chen; Qiqi Wang; Congcong Du; Wenbin Lu; Hong Yuan; Zhenzhen Zhang; Danqing Li; Xing Ling; Xiang Ren; Yang Zhao; Qi Su; Zhengcao Xing; Yuanyuan Qin; Xinyi Yang; Yajie Shen; Hongmei Wu; Yitao Qi
Journal:  J Mol Med (Berl)       Date:  2021-10-09       Impact factor: 4.599

Review 4.  Post-translational modifications of the Fragile X Mental Retardation Protein in neuronal function and dysfunction.

Authors:  Marta Prieto; Alessandra Folci; Stéphane Martin
Journal:  Mol Psychiatry       Date:  2019-12-10       Impact factor: 15.992

Review 5.  Impaired capacity to restore proteostasis in the aged brain after ischemia: Implications for translational brain ischemia research.

Authors:  Zhuoran Wang; Wei Yang
Journal:  Neurochem Int       Date:  2018-12-29       Impact factor: 3.921

6.  PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.

Authors:  Ayan Chanda; Yoshiho Ikeuchi; Kunal Karve; Anusi Sarkar; Amrita Singh Chandhoke; Lili Deng; Azad Bonni; Shirin Bonni
Journal:  Cell Death Differ       Date:  2020-08-07       Impact factor: 15.828

7.  Site-specific characterization of endogenous SUMOylation across species and organs.

Authors:  Ivo A Hendriks; David Lyon; Dan Su; Niels H Skotte; Jeremy A Daniel; Lars J Jensen; Michael L Nielsen
Journal:  Nat Commun       Date:  2018-06-25       Impact factor: 14.919

Review 8.  Involvement of the Protein Ras Homolog Enriched in the Striatum, Rhes, in Dopaminergic Neurons' Degeneration: Link to Parkinson's Disease.

Authors:  Marcello Serra; Annalisa Pinna; Giulia Costa; Alessandro Usiello; Massimo Pasqualetti; Luigi Avallone; Micaela Morelli; Francesco Napolitano
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

9.  Association of SUMOylation Pathway Genes With Stroke in a Genome-Wide Association Study in India.

Authors:  Amit Kumar; Ganesh Chauhan; Shriram Sharma; Surekha Dabla; P N Sylaja; Neera Chaudhary; Salil Gupta; Chandra Sekhar Agrawal; Kuljeet Singh Anand; Achal Kumar Srivastava; Deepti Vibha; Ram Sagar; Ritesh Raj; Ankita Maheshwari; Subbiah Vivekanandhan; Bhavna Kaul; Samudrala Raghavan; Sankar Prasad Gorthi; Dheeraj Mohania; Samander Kaushik; Rohtas Kanwar Yadav; Anjali Hazarika; Pankaj Sharma; Kameshwar Prasad
Journal:  Neurology       Date:  2021-05-24       Impact factor: 11.800

Review 10.  SUMOylation in development and neurodegeneration.

Authors:  Tak-Yu Yau; Oscar Molina; Albert J Courey
Journal:  Development       Date:  2020-03-18       Impact factor: 6.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.